|
PTER expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.90229999996738E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.597900E-04 |
| Normal-vs-Stage2 |
4.014300E-04 |
| Normal-vs-Stage3 |
1.09220000044097E-07 |
| Normal-vs-Stage4 |
6.55490000056602E-08 |
| Stage1-vs-Stage2 |
4.651400E-01 |
| Stage1-vs-Stage3 |
1.229740E-02 |
| Stage1-vs-Stage4 |
2.336400E-03 |
| Stage2-vs-Stage3 |
3.175000E-01 |
| Stage2-vs-Stage4 |
1.074830E-01 |
| Stage3-vs-Stage4 |
4.269400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.01319999957062E-08 |
| Normal-vs-AfricanAmerican |
1.882080E-02 |
| Normal-vs-Asian |
4.617400E-03 |
| Caucasian-vs-AfricanAmerican |
2.059000E-01 |
| Caucasian-vs-Asian |
9.801800E-02 |
| AfricanAmerican-vs-Asian |
9.839000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.415190E-04 |
| Normal-vs-Female |
1.69459999999066E-06 |
| Male-vs-Female |
5.439600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.041200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.14259999994815E-06 |
| Normal-vs-Age(61-80Yrs) |
1.73929999958133E-07 |
| Normal-vs-Age(81-100Yrs) |
1.154480E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.128200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.644200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.352400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.089600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.784100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.871700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.636200E-02 |
| Classical-VS-Follicular |
5.555800E-01 |
| Classical-VS-Other |
3.858400E-01 |
| Classical-VS-Normal |
1.59695999999432E-05 |
| Tall-VS-Follicular |
3.191700E-02 |
| Tall-VS-Other |
9.677600E-01 |
| Tall-VS-Normal |
7.46889999958533E-07 |
| Follicular-VS-Other |
1.371240E-01 |
| Follicular-VS-Normal |
4.023500E-03 |
| Other-VS-Normal |
1.128400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.91290000000266E-05 |
| Normal-vs-N1 |
4.20849999960282E-07 |
| N0-vs-N1 |
8.560200E-02 |
|
|
